Article
MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway
23 Oct 2017
Abstract excerpt
// Yan Shu 1 , Ligang Ren 1 , Bo Xie 1 , Zhen Liang 2 and Jing Chen 1 1 Department of Urology, Tongde Hospital of Zhejiang Province, Hangzhou 310012, China 2 Department of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China Correspondence to: Jing Chen, email: tdjingchen@163.com Keywords: prostate cancer, doxorubicin, miR-204, SIRT1, p53 Received: August 09, 2017...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
